Petitclerc É - Search Results

1

Predictors of participation restriction over a 9-year period in adults with myotonic dystrophy type 1.

Raymond K, Levasseur M, Gallais B, Richer L, Laberge L, Petitclerc É, Mathieu J, Gagnon C. Raymond K, et al. Among authors: petitclerc e. Disabil Rehabil. 2022 Jun;44(12):2615-2631. doi: 10.1080/09638288.2020.1837264. Epub 2020 Nov 2. Disabil Rehabil. 2022. PMID: 33135946

2

Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelines.

Petitclerc É, Hébert LJ, Desrosiers J, Gagnon C. Petitclerc É, et al. Muscle Nerve. 2015 Apr;51(4):473-8. doi: 10.1002/mus.24521. Epub 2015 Feb 25. Muscle Nerve. 2015. PMID: 25399769 Review.

3

Lower limb muscle strength impairment in late-onset and adult myotonic dystrophy type 1 phenotypes.

Petitclerc É, Hébert LJ, Mathieu J, Desrosiers J, Gagnon C. Petitclerc É, et al. Muscle Nerve. 2017 Jul;56(1):57-63. doi: 10.1002/mus.25451. Epub 2016 Nov 25. Muscle Nerve. 2017. PMID: 27784130

4

Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.

Kierkegaard M, Petitclerc E, Hébert LJ, Gagnon C. Kierkegaard M, et al. Among authors: petitclerc e. Neuromuscul Disord. 2017 Feb;27(2):153-158. doi: 10.1016/j.nmd.2016.11.018. Epub 2016 Dec 5. Neuromuscul Disord. 2017. PMID: 28062219

5

Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1.

Kierkegaard M, Petitclerc É, Hébert LJ, Mathieu J, Gagnon C. Kierkegaard M, et al. Among authors: petitclerc e. J Rehabil Med. 2018 Feb 28;50(3):269-277. doi: 10.2340/16501977-2304. J Rehabil Med. 2018. PMID: 29260836 Free article.

6

A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.

Gagnon C, Petitclerc É, Kierkegaard M, Mathieu J, Duchesne É, Hébert LJ. Gagnon C, et al. Among authors: petitclerc e. J Neurol. 2018 Jul;265(7):1698-1705. doi: 10.1007/s00415-018-8898-4. Epub 2018 May 21. J Neurol. 2018. PMID: 29785524

7

Relationships between Lower Limb Muscle Strength Impairments and Physical Limitations in DM1.

Petitclerc É, Hébert LJ, Mathieu J, Desrosiers J, Gagnon C. Petitclerc É, et al. J Neuromuscul Dis. 2018;5(2):215-224. doi: 10.3233/JND-170291. J Neuromuscul Dis. 2018. PMID: 29865087

8

Psychometric properties of a standardized protocol of muscle strength assessment by hand-held dynamometry in healthy adults: a reliability study.

Morin M, Hébert LJ, Perron M, Petitclerc É, Lake SR, Duchesne E. Morin M, et al. Among authors: petitclerc e. BMC Musculoskelet Disord. 2023 Apr 14;24(1):294. doi: 10.1186/s12891-023-06400-2. BMC Musculoskelet Disord. 2023. PMID: 37060020 Free PMC article.

9

C5a receptor antagonism coming of age for vascular pathology.

Marceau F, Petitclerc E. Marceau F, et al. Among authors: petitclerc e. Int Immunopharmacol. 2022 Sep;110:109042. doi: 10.1016/j.intimp.2022.109042. Epub 2022 Jul 14. Int Immunopharmacol. 2022. PMID: 35843145

10

Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships.

Fortin S, Wei L, Moreau E, Lacroix J, Côté MF, Petitclerc E, Kotra LP, Gaudreault RC. Fortin S, et al. Among authors: petitclerc e. Eur J Med Chem. 2011 Nov;46(11):5327-42. doi: 10.1016/j.ejmech.2011.08.034. Epub 2011 Aug 30. Eur J Med Chem. 2011. PMID: 21920638 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters